Injection Articles
BRAIN TUMOR GENE THERAPY: PHASE I
20 September 1993
INDIAN'S NEW DRUG PRICE CONTROL POLICY
13 September 1993
MATRIX EXPANDS CANCER TRIALS
23 August 1993
PHARMACEUTICAL EQUITIES: EVALUATION AND TRADING
9 August 1993
VIP TREATMENT FOR IMPOTENCE
9 August 1993
EUROPEAN CPMP MEETING IN JULY
26 July 1993
WHO APPROVES SHORT-TERM CONTRACEPTION INJECTION
28 June 1993
SURVIVAL TECHNOLOGY AND LIFEQUEST DEAL
28 June 1993
AMERSHAM'S METASTRON APPROVED IN USA
28 June 1993
BB-94 STARTS PHASE I/II CANCER TRIAL
14 June 1993
PREVENTING AIDS: PHASE I VACCINE STUDIES
14 June 1993
FIRST LAUNCH OF FUJISAWA'S PROGRAF
7 June 1993
MISOPROSTOL RAISES MIFEGYNE EFFICACY
31 May 1993
METASTRON REVIEWED
31 May 1993
FDA REAPPROVES STREPTOMYCIN
24 May 1993
PIXY321 RESULTS CONFIRM IMMUNEX POTENTIAL
24 May 1993
NEW INDICATION FOR LUPRON DEPOT-PED
10 May 1993
ARES-SERONO FILES NEW rFSH SUIT
26 April 1993
PASTEUR MERIEUX VACCINE DEVELOPMENTS
19 April 1993
LONG-TERM CALCITONIN MAINTAINS BONE MASS
19 April 1993
DEFIBRASE MARKETING
12 April 1993
AMERICAN HOME HAS CONFIDENCE FOR 1993
12 April 1993
SMITHKLINE BEECHAM LICENSES THREE DRUGS
5 April 1993
ZENECA TO PROMOTE METASTRON
5 April 1993
ZENECA ANTIBIOTIC IN MENINGITIS STUDY
5 April 1993
STI GAINS PATENT FOR AUTO-INJECTOR
15 March 1993
AUSTRALIA TO RESTRICT NEUPOGEN
15 March 1993
DELTA-WEST'S SELF-INJECTOR
8 March 1993
WELLCOME LAUNCHES MIVACRON
1 March 1993
Euro Community CPMP MEETING
1 March 1993
NAVOBAN LAUNCH
22 February 1993
SANOFI UNVEILS CNS DRUG CANDIDATE
8 February 1993
HONG KONG DOCTOR CLAIMS AIDS FINDING
8 February 1993
SIDE EFFECT WITH ENGERIX B VACCINE
1 February 1993
SYNERGEN, SELECTIDE R&D COLLABORATION
18 January 1993
IMITREX SLOW TO GROW, SAY ANALYSTS
18 January 1993
NEW PRODUCTS APPROVED IN UK
4 January 1993
UK FIRMS BOOSTED BY YEAR-END US APPROVALS
4 January 1993
GP120 TO ENTER PHASE II TRIALS
21 December 1992
GLAXO'S IMITREX GETS FDA BACKING IN USA
14 December 1992
SUPPLEMENTAL NDA FOR FOSCAVIR
7 December 1992
B-MS' PROHANCE APPROVED IN USA
7 December 1992
SANOFI WINTHROP AGREEMENT
9 November 1992
EISAI PLANT OPENS
2 November 1992
PFIZER EXTENDS UK FELDENE RANGE
12 October 1992
GYNEX' SUBLINGUAL TESTOSTERONE
5 October 1992
MENINGITIS STUDY
3 August 1992
TAKEDA NEW SUSTAIN RELEASE DEVELOPMENT
3 August 1992
NEW DRUGS HIGHLIGHTED AT AIDS CONFERENCE
3 August 1992
DATA FROM SANDOZ' DHE-45 TRIAL
6 July 1992
HEALTH CARE NEEDS IN CENTRAL ASIA
29 June 1992
US NIH "GO-AHEAD" TO GENETIC THERAPY TRIALS
15 June 1992
EVANS LAUNCHES VIVOTIF IN UK
15 June 1992
BIOMIRA UPDATES ON PRODUCT PROGRESS
8 June 1992
Liposome Technology trial results
1 June 1992
UK LAUNCH OF MERIEUX' TYPHIM Vi
25 May 1992
ROCEPHIN CURES HEART INFECTIONS
18 May 1992
SERONO ACHIEVES IVF SUCCESS WITH rhFSH
18 May 1992
ZOLADEX GAINS BREAST CANCER INDICATION IN UK
18 May 1992
LILLY/BIOJECT DEAL
11 May 1992
CONNAUGHT'S VACCINE RESEARCH PROGRAM
11 May 1992
ROUSSEL JAPAN CASH INJECTION
4 May 1992
EMIP STUDY BACKS EARLY USE OF EMINASE
4 May 1992
MERCK & MERIEUX VACCINE DEAL
27 April 1992
FISONS TO COPROMOTE EPIPEN
20 April 1992
GENETIC IMMUNIZATION ADVANCE
23 March 1992
US APPRO FOR ISIS' ANTISENSE TRIAL
16 March 1992
IL-2 APPROVED IN UK
9 March 1992
MAbs MAY PROVIDE MS TREATMENT
9 March 1992
ADVANCE IN DIABETES RESEARCH
3 February 1992
SHIONOGI LAUNCHES HUMULIN U IN JAPAN
3 February 1992
HEALTH ISSUES IN BRAZIL
3 February 1992
A REAL NEED FOR SB'S HAVRIX, MEETING HEARS
3 February 1992
HOECHST RESEARCH: A "TRI-REGIONAL" FOCUS
20 January 1992
CELTRIX TO BECOME MAJOR BIOTECH PLAYER
13 January 1992
ELI LILY EXPANDS IN FRANCE
6 January 1992
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
